F Hugo

3.1k total citations · 1 hit paper
41 papers, 2.6k citations indexed

About

F Hugo is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, F Hugo has authored 41 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 18 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in F Hugo's work include Complement system in diseases (16 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Biochemical and Structural Characterization (5 papers). F Hugo is often cited by papers focused on Complement system in diseases (16 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Biochemical and Structural Characterization (5 papers). F Hugo collaborates with scholars based in Germany, Czechia and Tunisia. F Hugo's co-authors include Sucharit Bhakdi, E. Eigenbrodt, Sybille Mazurek, C. B. Boschek, M Muhly, H. Schäfer, D Mathey, S Bhakdi, Dieter E. Jenne and Stephan Korom and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

F Hugo

41 papers receiving 2.5k citations

Hit Papers

Pyruvate kinase type M2 and its role in tumor growth and ... 2005 2026 2012 2019 2005 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pyruvate kinase type M2 and its role in tumor growth and spreading
    2005 670 citations Sybille Mazurek, C. B. Boschek et al. Seminars in Cancer Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Hugo Germany 26 1.1k 804 551 260 257 41 2.6k
Philip Furmanski United States 27 1.1k 1.0× 487 0.6× 347 0.6× 240 0.9× 354 1.4× 106 3.0k
R G Crystal United States 28 1.3k 1.2× 518 0.6× 522 0.9× 291 1.1× 242 0.9× 48 3.4k
Jonathon W. Homeister United States 22 722 0.7× 595 0.7× 138 0.3× 233 0.9× 239 0.9× 58 2.1k
L Osborn United States 17 1.1k 1.0× 1.6k 2.0× 638 1.2× 200 0.8× 395 1.5× 21 3.6k
Evangelia Komisopoulou United States 15 791 0.7× 616 0.8× 344 0.6× 199 0.8× 134 0.5× 16 1.9k
Colin Longstaff United Kingdom 30 739 0.7× 462 0.6× 510 0.9× 215 0.8× 980 3.8× 96 3.0k
Steven D. Carson United States 30 965 0.9× 406 0.5× 190 0.3× 431 1.7× 819 3.2× 96 2.9k
Nathalie Heuzé‐Vourc'h France 31 896 0.8× 692 0.9× 345 0.6× 111 0.4× 149 0.6× 94 2.9k
Abraham Mittelman United States 30 1.7k 1.6× 1.2k 1.5× 190 0.3× 158 0.6× 398 1.5× 131 3.9k
Arne Lundblad Sweden 34 2.0k 1.9× 580 0.7× 161 0.3× 221 0.8× 393 1.5× 134 3.7k

Countries citing papers authored by F Hugo

Since Specialization
Citations

This map shows the geographic impact of F Hugo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Hugo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Hugo more than expected).

Fields of papers citing papers by F Hugo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Hugo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Hugo. The network helps show where F Hugo may publish in the future.

Co-authorship network of co-authors of F Hugo

This figure shows the co-authorship network connecting the top 25 collaborators of F Hugo. A scholar is included among the top collaborators of F Hugo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Hugo. F Hugo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seeger, Werner, et al.. (2007). Listeriose bei einem Patienten mit Hämodialyse und Eisenüberladung. Medizinische Klinik. 102(6). 483–485. 3 indexed citations
2.
Mazurek, Sybille, C. B. Boschek, F Hugo, & E. Eigenbrodt. (2005). Pyruvate kinase type M2 and its role in tumor growth and spreading. Seminars in Cancer Biology. 15(4). 300–308. 670 indexed citations breakdown →
3.
Hugo, F, G. Fischer, & E. Eigenbrodt. (1999). Quantitative detection of tumor M2-PK in serum and plasma.. PubMed. 19(4A). 2753–7. 23 indexed citations
4.
Mazurek, S., F Hugo, Klaus Failing, & E. Eigenbrodt. (1996). Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: Role of P36. Journal of Cellular Physiology. 167(2). 238–250. 37 indexed citations
5.
Menestrina, Gianfranco, et al.. (1995). Binding of antibodies to functional epitopes on the pore formed by Escherichia coli hemolysin in cells and model membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1238(1). 72–80. 6 indexed citations
6.
Mathey, D, et al.. (1994). Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. European Heart Journal. 15(3). 418–423. 74 indexed citations
7.
Hugo, F, et al.. (1992). In vitro effect of extracellular AMP on MCF‐7 breast cancer cells: Inhibition of glycolysis and cell proliferation. Journal of Cellular Physiology. 153(3). 539–549. 41 indexed citations
8.
Seeger, Werner, Michael J. Thomas, D. Walmrath, et al.. (1991). Lung Vascular Injury after Administration of Viable Hemolysin-forming Escherichia coli in Isolated Rabbit Lungs. American Review of Respiratory Disease. 143(4_pt_1). 797–805. 23 indexed citations
9.
Bhakdi, Sucharit, F Hugo, & Jørgen Tranum‐Jensen. (1990). Functions and relevance of the terminal complement sequence. Annals of Hematology. 60(6). 309–318. 29 indexed citations
10.
Seifert, Paul S., F Hugo, J Tranum-Jensen, et al.. (1990). Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions.. The Journal of Experimental Medicine. 172(2). 547–557. 123 indexed citations
11.
Bhakdi, Sucharit, et al.. (1989). Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes.. The Journal of Experimental Medicine. 169(3). 737–754. 113 indexed citations
12.
Lohmann, W. & F Hugo. (1989). The effect of NADH on different human and mouse cell lines. Die Naturwissenschaften. 76(2). 72–74. 6 indexed citations
13.
Bhakdi, Sucharit, et al.. (1989). Biotinylation: a simple method for labelling complement component C8 with preservation of functional activity. Journal of Immunological Methods. 121(1). 61–66. 8 indexed citations
14.
Bhakdi, Sucharit, et al.. (1988). Relative inefficiency of terminal complement activation.. The Journal of Immunology. 141(9). 3117–3122. 51 indexed citations
15.
Bhakdi, Sucharit, et al.. (1988). Staphylococcal α toxin promotes blood coagulation via attack on human platelets. The Journal of Experimental Medicine. 168(2). 527–542. 106 indexed citations
16.
Salama, A., F Hugo, D. Heinrich, et al.. (1988). Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary Bypass. New England Journal of Medicine. 318(7). 408–414. 123 indexed citations
17.
Bhakdi, Sucharit, Nigel Mackman, Gianfranco Menestrina, et al.. (1988). The hemolysin of escherichia coli. European Journal of Epidemiology. 4(2). 135–143. 55 indexed citations
18.
Hugo, F, et al.. (1987). A natural auto-inhibitory factor of the terminal complement pathway in serum of Ctenodactylus gondi. Molecular Immunology. 24(5). 543–548. 4 indexed citations
19.
Hugo, F, et al.. (1987). Identification with monoclonal antibodies of hemolysin produced by clinical isolates of Escherichia coli. Journal of Clinical Microbiology. 25(1). 26–30. 26 indexed citations
20.
Schäfer, H., D Mathey, F Hugo, & Sucharit Bhakdi. (1986). Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.. The Journal of Immunology. 137(6). 1945–1949. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Furmanski Breakdown of academic impact, for papers by R G Crystal Breakdown of academic impact, for papers by Jonathon W. Homeister Breakdown of academic impact, for papers by L Osborn Breakdown of academic impact, for papers by Evangelia Komisopoulou Breakdown of academic impact, for papers by Colin Longstaff Breakdown of academic impact, for papers by Steven D. Carson Breakdown of academic impact, for papers by Nathalie Heuzé‐Vourc'h Breakdown of academic impact, for papers by Abraham Mittelman Breakdown of academic impact, for papers by Arne Lundblad
Rankless by CCL
2026